Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes.
about
Understanding platelet generation from megakaryocytes: implications for in vitro-derived plateletsTranscription factors in late megakaryopoiesis and related platelet disordersNeonatal expression of RNA-binding protein IGF2BP3 regulates the human fetal-adult megakaryocyte transition.Two patterns of thrombopoietin signaling suggest no coupling between platelet production and thrombopoietin reactivity in thrombocytopenia-absent radii syndromeCellular-based therapies to prevent or reduce thrombocytopenia.Long-term mTOR inhibitors administration evokes altered calcium homeostasis and platelet dysfunction in kidney transplant patients.Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice.Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan.Understanding thrombocytopenia: physiological role of microRNA in survival of neonatal megakaryocytes.Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodiesPrognostic significance of early platelet count decline in preterm newbornsSafety and Efficacy of Megakaryocytes Induced from Hematopoietic Stem Cells in Murine and Nonhuman Primate ModelsDevelopmental differences between newborn and adult mice in response to romiplostim.Human haemato-endothelial precursors: cord blood CD34+ cells produce haemogenic endotheliumDifferential Reponses of Hematopoietic Stem and Progenitor Cells to mTOR Inhibition.Developmental changes in hematopoietic stem cell properties.mTORC1 promotes aging-related venous thrombosis in mice via elevation of platelet volume and activation.miR-125b modulates megakaryocyte maturation by targeting the cell-cycle inhibitor p19INK4D.Challenges and promises for the development of donor-independent platelet transfusions.MiR-9 contributes to the developmental differences in CXCR-4 expression in human megakaryocytes.AKT collaborates with ERG and Gata1s to dysregulate megakaryopoiesis and promote AMKL.Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.Megakaryocyte ontogeny: Clinical and molecular significance.Increased expression of transient receptor potential canonical 6 (TRPC6) in differentiating human megakaryocytes.
P2860
Q26770860-8DDF2F0E-DF06-4BA9-AA0F-CE6321CF357EQ27015841-6049AC8D-DB1D-4768-9119-A197163BA43CQ30252483-94F57BBA-07E2-4FB7-99DD-121E1C32F6FEQ33397292-C578197C-82B2-469F-870B-82212A5A8FC2Q33398164-F86F4C25-4750-4DE8-8DC1-6C1BAAB28C70Q33407003-23581BE7-663E-4110-99A6-61556605A8FDQ33409352-947684DB-748E-4050-A4EF-A3E07ED0878BQ33413694-D5795D25-B552-4E4B-BF6B-61FAEBEB4EECQ33423497-39A9E09F-2C0A-422B-9921-A44BDBF18397Q33424728-FEFB1934-E1CE-4E0C-B3BC-4DCD7321CF08Q33425531-60129767-71DB-456A-87EC-26794849373FQ33440176-FB54EC75-C3CE-49D9-9B3E-9B73E7908694Q33442148-8E0E78C6-668D-471D-816E-09664FB40287Q34506724-278133F6-9E4A-4C02-B3C0-3E5723E77B63Q35843230-A835D361-CED1-4ED8-88F4-9CEB2A6121ACQ37361585-4AA396AF-85F2-47CC-8A43-E8FDA3EFFB05Q37396328-D8BC6BA9-1F3A-4281-B8E2-30483335C5BFQ37465842-CCEC4FD7-B830-453E-8699-43EBD63FA56AQ38074224-4AEC1AFD-E231-4468-BEAE-326861473657Q38796632-22C538CE-16A9-4C0C-9325-570E2B328A50Q39199734-6524957E-9ACA-4384-8BFE-6241D5D1B3B4Q50048420-4614845B-BCAB-4CD1-ADD8-A6227ED22DA9Q52675907-3C89B0BF-C681-49EB-972A-CFC69A0DF8DCQ58955287-FDF8AC78-791B-42F8-BC33-B6F23DFB5119
P2860
Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Developmental differences in m ...... ls in neonatal megakaryocytes.
@ast
Developmental differences in m ...... ls in neonatal megakaryocytes.
@en
type
label
Developmental differences in m ...... ls in neonatal megakaryocytes.
@ast
Developmental differences in m ...... ls in neonatal megakaryocytes.
@en
prefLabel
Developmental differences in m ...... ls in neonatal megakaryocytes.
@ast
Developmental differences in m ...... ls in neonatal megakaryocytes.
@en
P2093
P2860
P1433
P1476
Developmental differences in m ...... ls in neonatal megakaryocytes.
@en
P2093
Brandon Poterjoy
Joseph Italiano
Lisa Rimsza
Martha Sola-Visner
Matthew Bailey
Zhi-Jian Liu
P2860
P304
P356
10.1182/BLOOD-2010-07-293092
P407
P577
2011-02-08T00:00:00Z